SAN MATEO, Calif.–(BUSINESS WIRE)–The numbers speak for themselves, RapidAI’s deep clinical AI is delivering results where competitors are falling short. New data from the largest head-to-head study to date proves RapidAI’s LVO detection outperforms Viz.ai by a staggering 33%, detecting far more stroke cases and reducing the risk of missed diagnoses. These findings, along with 17 influential studies, will be showcased at the American Heart Association’s International Stroke Conference (ISC) i
More in Uncategorized
Uncategorized
73% of Organizations with up to 2,000 Employees Rely on MSPs to Manage the Security Challenges of Growth
New International Research Shows Companies Struggle with IT Complexity, Spiraling Tool Sprawl and ...
Uncategorized
eScan Introduces Revolutionary Workspace Tenant Control – Ensuring Corporate Data Stays within Corporate Boundaries
~Seamless Productivity Meets Enterprise-Grade Security in a Hybrid Work Era~ Mumbai, July 18, ...
Uncategorized
Microvast Unveils Next-Gen Battery Solutions at Smart Energy Week 2025
STAFFORD, Texas–(BUSINESS WIRE)–Microvast Holdings, Inc. (NASDAQ: MVST) (“Microvast” or the “Company”), a global ...